Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion type Assertion NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_head.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion description "[Here we investigate the capability of protein 14-3-3, total-tau (t-tau), threonin-181-phosphorylated tau (p-tau), and neuron-specific enolase (NSE) in cerebrospinal fluid (CSF) together with the prion protein gene genotype to discriminate patients with sCJD (n=21) from neurological controls (n=164) and Alzheimer's disease (AD) patients (n=49).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion evidence source_evidence_literature NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion SIO_000772 18339451 NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion wasDerivedFrom befree-2016 NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.
- NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_assertion wasGeneratedBy ECO_0000203 NP660494.RApIp9HZ_n57zN3wtHb_IbrVNi4Ea3O568qwAkLA9XZlU130_provenance.